Jinhe Biotechnology Co. Ltd. (002688.SZ)
002688.SZ Stock Price Chart
Explore Jinhe Biotechnology Co. Ltd. interactive price chart. Choose custom timeframes to analyze 002688.SZ price movements and trends.
002688.SZ Company Profile
Discover essential business fundamentals and corporate details for Jinhe Biotechnology Co. Ltd. (002688.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
13 Jul 2012
Employees
2.32K
Website
https://www.jinhe.com.cnCEO
Changxian Xie
Description
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. The company was founded in 1990 and is based in Dalian, China.
002688.SZ Financial Timeline
Browse a chronological timeline of Jinhe Biotechnology Co. Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jul 2025
EPS came in at ¥0.12 , while revenue for the quarter reached ¥765.11M .
Dividend declared on 6 Jun 2025
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 6 Jun 2025.
Earnings released on 26 Apr 2025
EPS came in at -¥0.02 , while revenue for the quarter reached ¥713.35M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.07 , while revenue for the quarter reached ¥625.15M .
Earnings released on 27 Oct 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥591.53M .
Earnings released on 28 Aug 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥546.30M .
Dividend declared on 31 May 2024
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 31 May 2024.
Earnings released on 20 May 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥519.45M .
Earnings released on 28 Apr 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥604.29M .
Earnings released on 29 Oct 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥537.37M .
Earnings released on 22 Aug 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥505.19M .
Dividend declared on 5 Jun 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 5 Jun 2023.
Earnings released on 27 Apr 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥527.29M .
Earnings released on 22 Apr 2023
EPS came in at -¥0.03 , while revenue for the quarter reached ¥489.85M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥507.44M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.07 , while revenue for the quarter reached ¥605.65M .
Earnings released on 22 Apr 2022
EPS came in at -¥0.04 , while revenue for the quarter reached ¥639.08M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.05 , while revenue for the quarter reached ¥519.77M .
Earnings released on 25 Oct 2021
EPS came in at ¥0.01 , while revenue for the quarter reached ¥477.91M .
Earnings released on 23 Aug 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥498.84M .
Dividend declared on 30 Apr 2021
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 30 Apr 2021.
Earnings released on 20 Apr 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥607.58M .
Earnings released on 30 Mar 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥462.17M .
Earnings released on 26 Oct 2020
EPS came in at ¥0.01 , while revenue for the quarter reached ¥358.63M .
002688.SZ Stock Performance
Access detailed 002688.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.